Lee Danner & Bass Inc Viatris Inc Transaction History

Lee Danner & Bass Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$8.72 - $11.56 $42,789 - $56,724	-4,907 Reduced 32.91%	10,002 $111,000
Q3 2022 Oct 31, 2022	SELL	$8.48 - $11.13 $2,739 - $3,594	-323 Reduced 2.12%	14,909 $127,000
Q2 2022 Jul 25, 2022	SELL	$9.95 - $12.27 $1,989 - $2,454	-200 Reduced 1.3%	15,232 $159,000
Q1 2022 Apr 27, 2022	SELL	$9.81 - $15.4 $9,515 - $14,938	-970 Reduced 5.91%	15,432 $168,000
Q4 2021 Jan 27, 2022	SELL	$12.09 - $14.68 $78,500 - $95,317	-6,493 Reduced 28.36%	16,402 $222,000
Q3 2021 Nov 01, 2021	BUY	$13.25 - $15.13 $54,563 - $62,305	4,118 Added 21.93%	22,895 $310,000
Q2 2021 Jul 27, 2021	SELL	$12.97 - $16.15 $4,604 - $5,733	-355 Reduced 1.86%	18,777 $268,000
Q1 2021 Apr 29, 2021	SELL	$13.59 - $18.54 $8,982 - $12,254	-661 Reduced 3.34%	19,132 $267,000
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $283,039 - $370,920	19,793 New	19,793 $371,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

Stay updated on Lee Danner & Bass Inc with notifications on news.